Standout Papers
Citation Impact
Citing Papers
Probing mucin-type O-linked glycosylation in living animals
2006 StandoutNobel
Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data
1997 Standout
Hypoxia Response Elements in the Aldolase A, Enolase 1, and Lactate Dehydrogenase A Gene Promoters Contain Essential Binding Sites for Hypoxia-inducible Factor 1
1996 StandoutNobel
Soft Tissue Leiomyosarcomas and Malignant Gastrointestinal Stromal Tumors: Differences in Clinical Outcome and Expression of Multidrug Resistance Proteins
2000
The relationship between prognostic and predictive factors in the management of breast cancer
1998
Triple-Negative Breast Cancer
2010 Standout
The molecular underpinning of lobular histological growth pattern: a genome‐wide transcriptomic analysis of invasive lobular carcinomas and grade‐ and molecular subtype‐matched invasive ductal carcinomas of no special type
2009
Bioorthogonal Chemistry: Fishing for Selectivity in a Sea of Functionality
2009 StandoutNobel
Differences in Risk Factors for Local and Distant Recurrence After Breast-Conserving Therapy or Mastectomy for Stage I and II Breast Cancer: Pooled Results of Two Large European Randomized Trials
2001
A randomised phase II study on neo-adjuvant chemotherapy for ‘high-risk’ adult soft-tissue sarcoma
2001
Suppression of tumor growth through disruption of hypoxia-inducible transcription
2000 StandoutNobel
Long-term results of the co-operative German–Austrian–Swiss osteosarcoma study group’s protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs
1998
Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities.
1996 Standout
Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer
2013 Standout
pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐up
1991 Standout
International Collaboration is Feasible in Trials for Rare Conditions: The EURAMOS Experience
2009
A Randomized Comparison of Sentinel-Node Biopsy with Routine Axillary Dissection in Breast Cancer
2003 Standout
Effect of the Tyrosine Kinase Inhibitor STI571 in a Patient with a Metastatic Gastrointestinal Stromal Tumor
2001 Standout
Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer
1989
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
2008 Standout
Cytotoxic and hormonal treatment for metastatic breast cancer: a systematic review of published randomized trials involving 31,510 women.
1998
Induction chemotherapy and radiotherapy in locally advanced non–small cell lung cancer
2004
Histological grading of breast carcinomas: A study of interobserver agreement
1995
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation
2000 Standout
Twenty-Year Follow-up of a Randomized Study Comparing Breast-Conserving Surgery with Radical Mastectomy for Early Breast Cancer
2002 Standout
Intensified Adjuvant IFADIC Chemotherapy for Adult Soft Tissue Sarcoma: A Prospective Randomized Feasibility Trial
2000
Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
1995
Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial
1996
Refinement of clinicopathologic staging for localized soft tissue sarcoma of the extremity: a study of 423 adults.
1992
Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup
1997
Two-Stage Revision for Infected Endoprostheses Used in Tumor Surgery
2002
Adjuvant chemotherapy for soft-tissue sarcoma: review and meta-analysis of the published results of randomised clinical trials
1995
Twenty-Year Follow-up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy plus Irradiation for the Treatment of Invasive Breast Cancer
2002 Standout
Alveolar rhabdomyosarcomas in conditional Pax3:Fkhr mice: cooperativity of Ink4a/ARF and Trp53 loss of function
2004 StandoutNobel
Diagnostic and therapeutic management of cancer of an unknown primary
2003
Pathological prognostic factors in breast cancer
1999 Standout
3 The Medicinal Chemistry of the Azido Group
1994
Long-Term Results of Hypofractionated Radiation Therapy for Breast Cancer
2010 Standout
Progression-free rate as the principal end-point for phase II trials in soft-tissue sarcomas
2002
Hypoxia Inhibits G1/S Transition through Regulation of p27 Expression
2001 StandoutNobel
Chemotherapy for Osteosarcoma without High-Dose Methotrexate: A 12-Year Follow-Up on 53 Patients
2007
Late consolidative radiation therapy in the treatment of limited-stage small cell lung cancer
1991
A randomized study of radiation treatment in small cell bronchial carcinoma treated with two types of four-drug chemotherapy regimens
1988
Tumor size and prognosis in aggressively treated osteosarcoma.
1996
Prognostication in soft tissue sarcoma.A model with four risk factors
1988
Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group.
1993 Standout
Bone tumours in European children and adolescents, 1978–1997. Report from the Automated Childhood Cancer Information System project
2006
Lysosomes and endoplasmic reticulum: Targets for improved, selective anticancer therapy
2005
Activity of eribulin mesylate in patients with soft-tissue sarcoma: a phase 2 study in four independent histological subtypes
2011
GATA-3 Links Tumor Differentiation and Dissemination in a Luminal Breast Cancer Model
2008
Prognostic value of histologic grade nuclear components of Scarff-Bloom-Richardson (SBR). An improved score modification based on a multivariate analysis of 1262 invasive ductal breast carcinomas
1989
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Cosmetic results following lumpectomy axillary dissection and radiotherapy for small breast cancers
1988
Predictive factors of disease-free survival for non-metastatic osteosarcoma of the extremity: An analysis of 300 patients treated at the Rizzoli Institute
2001
Impact of the cyclin–dependent kinase inhibitor p27Kip1 on resistance of tumor cells to anticancer agents
1996
Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast Carcinoma
1991 Standout
Cathepsin D—Many functions of one aspartic protease
2008
Autophagy and Aging
2011 Standout
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
2004 Standout
Cardiac Exposures in Breast Cancer Radiotherapy: 1950s–1990s
2007
Complications of Endoscopic Biliary Sphincterotomy
1996 Standout
Long-Term Results of a Randomized Trial Comparing Breast-Conserving Therapy With Mastectomy: European Organization for Research and Treatment of Cancer 10801 Trial
2000
Delaying surgery with chemotherapy for osteosarcoma of the extremities
2004
MicroRNA expression profiles classify human cancers
2005 StandoutNatureNobel
Adjuvant Epirubicin With or Without Ifosfamide for Adult Soft-Tissue Sarcoma
2002
Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2
2001 Standout
The Hallmarks of Aging
2013 Standout
Improvement in Histologic Response But Not Survival in Osteosarcoma Patients Treated With Intensified Chemotherapy: A Randomized Phase III Trial of the European Osteosarcoma Intergroup
2007
Quantifying heterogeneity in a meta‐analysis
2002 Standout
Treatment of Infections Associated with Surgical Implants
2004 Standout
Cathepsin-D in primary breast cancer: prognostic evaluation involving 2810 patients
1998
Ovarian carcinoma preceded by cerebral metastasis: Review of the literature
1992
Histological Grading of Breast Cancer
1990
Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial
2012 Standout
Prognostic factors in soft tissue sarcomas. A multivariate analysis of 109 cases
1989
Common Musculoskeletal Tumors of Childhood and Adolescence
1999
Cancer of the Ovary
2004 Standout
Late local recurrences in a randomised trial comparing conservative treatment with total mastectomy in early breast cancer patients
2003
Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes
2002 StandoutScience
Five-Year Results of a Randomized Clinical Trial Comparing Total Mastectomy and Segmental Mastectomy with or without Radiation in the Treatment of Breast Cancer
1985 Standout
Head and Neck Cancer
2020 Standout
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
2001 Standout
Lysosomal cathepsin D mediates endogenous mucin glycodomain catabolism in mammals
2022 StandoutNobel
Occurrence, Biogenesis, and Synthesis of Biologically Active Carbazole Alkaloids
2012 Standout
Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma.
1996 Standout
Randomized Phase III Study Comparing Conventional-Dose Doxorubicin Plus Ifosfamide Versus High-Dose Doxorubicin Plus Ifosfamide Plus Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor in Advanced Soft Tissue Sarcomas: A Trial of the European Organization for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group
2000
Multiplex reverse transcription polymerase chain reaction assessment of sialyltransferase expression in human breast cancer.
1998
Prognostic Factors in High-Grade Osteosarcoma of the Extremities or Trunk: An Analysis of 1,702 Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols
2002 Standout
Adjuvant Chemotherapy for Soft Tissue Sarcomas
1991
The Risk of Determining Risk with Multivariable Models
1993 Standout
Therapy of small cell lung cancer: a perspective on two decades of clinical research.
1988
Adjuvant Therapy Of Soft-Tissue Sarcomas
1995
Breast cancer: Relationship between the size of the primary tumour and the probability of metastatic dissemination
1984
Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth
1997 StandoutNobel
The treatment of soft tissue sarcomas with focus on chemotherapy: A review
1986
Nuclear repartitioning of galectin-1 by an extracellular glycan switch regulates mammary morphogenesis
2016 StandoutNobel
Prognostic Significance of a Novel Hypoxia-Regulated Marker, Carbonic Anhydrase IX, in Invasive Breast Carcinoma
2001 StandoutNobel
Adjuvant Chemotherapy for Adult Soft Tissue Sarcomas of the Extremities and Girdles: Results of the Italian Randomized Cooperative Trial
2001
Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells
2012 StandoutNobel
Adjuvant Chemotherapy for Soft Tissue Sarcomas
1995
Applications of Palladium-Catalyzed C–N Cross-Coupling Reactions
2016 Standout
Chemotherapy Alone or Chemotherapy with Chest Radiation Therapy in Limited Stage Small Cell Lung Cancer
1987
Canadian multicenter randomized trial comparing sequential and alternating administration of two non-cross-resistant chemotherapy combinations in patients with limited small-cell carcinoma of the lung.
1987
Osteosarcoma: Current Treatment and a Collaborative Pathway to Success
2015 Standout
Inhibitors of human immunodeficiency virus integrase.
1993 StandoutNobel
The surgeon's role in primary breast cancer
1981
Isolation and Synthesis of Biologically Active Carbazole Alkaloids
2002 Standout
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials
2005 Standout
Prognostic Factors in High-Grade Osteosarcoma of the Extremities or Trunk: An Analysis of 1,702 Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols
2002 Standout
Presurgical Chemotherapy Compared With Immediate Surgery and Adjuvant Chemotherapy for Nonmetastatic Osteosarcoma: Pediatric Oncology Group Study POG-8651
2003
Works of Jacques Rouëssé being referenced
Sequential cytopunctures during preoperative chemotherapy for primary breast carcinoma. II. DNA flow cytometry changes during chemotherapy, tumor regression, and short-term follow-up
1992
Sequential cytopunctures during preoperative chemotherapy for primary breast carcinoma. Cytomorphologic changes, initial tumor ploidy, and tumor regression
1989
Response to neoadjuvant chemotherapy in lobular and ductal breast carcinomas: a retrospective study on 860 patients from one institution
2006
Granulocyte-macrophage colony-stimulating factor allows safe escalation of dose-intensity of chemotherapy in metastatic adult soft tissue sarcomas: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
1993
A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: the first study of the European Osteosarcoma Intergroup.
1992
Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma--reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
1994
Phase II study of mitozolomide in advanced soft tissue sarcoma of adults: the EORTC Soft Tissue and Bone Sarcoma Group
1992
Evaluation of breast carcinoma chemosensitivity by flow cytometric DNA analysis and computer assisted image analysis
1992
A phase II study of M-azido-pyrimethamine ethane sulphonate (MZPES) in advanced, recurrent soft tissue sarcoma
1989
CATHEPSIN D: AN INDEPENDENT PROGNOSTIC FACTOR FOR METASTASIS OF BREAST CANCER
1989
Soft‐tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system
1984 Standout
Twelve-year experience with chemotherapy in adult metastatic renal cell carcinoma at the Institut Gustave-Roussy.
1988
Conservative treatment versus mastectomy in breast cancer tumors with macroscopic diameter of 20 millimeters or less the experience of the institut gustave-roussy
1984
Phase II study of cisplatin in advanced osteogenic sarcoma. European Organization for Research on Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
1985
Sites of primary malignancies in patients presenting with cerebral metastases.A review of 120 cases
1985
The importance of histologic grade in long-term prognosis of breast cancer: a study of 1,010 patients, uniformly treated at the Institut Gustave-Roussy.
1987
Reproducibility of a histopathologic grading system for adult soft tissue sarcoma
1986
[Prognostic factors in breast cancer].
1978
[The anatomopathological factors of prognostic value in breast cancer].
1977
Randomized phase II study of neoadjuvant chemotherapy in soft tissue sarcomas in adults. Protocol 62874
1993
Alternating radiotherapy and chemotherapy schedules in small cell lung cancer, limited disease
1985
Combined chemotherapy (vindesine, lomustine, cisplatin, and cyclophosphamide) and radical radiotherapy in inoperable nonmetastatic squamous cell carcinoma of the lung
1986
Preoperative induction chemotherapy in the treatment of locally advanced soft tissue sarcomas
1987
Antitumor Activity, Pharmacology, and Toxicity of Ellipticines, Ellipticinium, and 9-Hydroxy Derivatives: Preliminary Clinical Trials of 2-Methyl-9-Hydroxy Ellipticinium (NSC 264-137)
1980
Aminoglutethimide in advanced breast cancer: Clinical results of a French multicenter randomized trial comparing 500 mg and 1 g/day
1985